Q&A with Marcus Boggs: Practicing open-book management
THE GAZETTE
Marcus Boggs has shared both financial results and profits with employees of CEA Technologies Inc. since he started the privately held contract medical device engineering and manufacturing company in Colorado Springs in 1988.
News
The Gazette with CEA Technologies
Ariel Appoints Dr. Catherine Sohn to BoD
Broomfield, CO, March 30, 2012 – Ariel Pharmaceuticals, Inc., a private, development-stage specialty pharmaceutical company focused on the development and commercialization of therapeutic products for major unmet medical needs, announced today that Catherine Angell Sohn, Pharm.D., CLP,
has been appointed as an independent director to Ariel's board of directors.
ZILA acquires product portfolios
ZILA, Inc. a TOLMAR Company, acquires the soft tissue diode laser, Zen™ and Insight™ product portfolios from Discus Dental.
PharmaJet Wins Innovative Technology Award
Jefferson County's 19th Annual Industry Awards ceremony, honoring leading businesses in Colorado's Jefferson County.
Clovis Oncology files for $75M stock offering
Denver Business Journal
Ventria Bioscience and EMD Millipore Announce Exclusive Agreement
Ventria Bioscience and EMD Millipore Announce Exclusive Global Supply and Marketing Agreement
Ventria to use ExpressTec to manufacture and supply materials for animal component-free cell culture products
Supreme Court rejects 2 personalized medicine patents
The U.S. Supreme Court has thrown out two patents held by Prometheus Laboratories involving a blood test that helps doctors determine the best dosage for thiopurine for treating patients with autoimmune disease. Prometheus' method of monitoring a patient and adjusting dosage as needed is based on laws of nature and cannot be patented, the court said. The ruling could threaten existing patents and discourage future patent applications involving personalized medicine. BIO is "surprised and disappointed in the court's decision," said deputy general counsel Hans Sauer.
CBSA Commends PhRMA and We Work For Health for Clinical Trial Report
Colorado BioScience Association Commends PhRMA and We Work For Health for Showcasing
the Critical Importance of Clinical Trials to Chronic Disease Sufferers in the State
DBJ-Surefire, Intio take unique approaches to tech development
Denver-area companies Surefire Medical Inc. and Intio share a lot of traits that distinguish them from typical bioscience companies.
































